Rogers Corp. Stock News

CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE: ROG) (“Rogers”) today presented its strategy to accelerate growth, expand profitability and increase earnings through 2030 at the Company's 2026 Investor Day. The event featured presentations from Ali El-Haj, Rogers' President and Chief Executive Officer; Laura Russell, Senior Vice President and Chief Financial Officer; and other membe...

CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”) will host an Investor Day, Wednesday, September 30, 2026, in New York City. The event will include presentations from Ali El-Haj, Rogers' President and Chief Executive Officer; Laura Russell, Senior Vice President and Chief Financial Officer; and other members of the leadership team. An interactive Q&A session will follo...

CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) (“Rogers”) today announced that it will host an Investor Day on Wednesday, September 30, 2026, in New York City. Rogers' President and CEO Ali El-Haj and other members of the senior leadership team will provide details on Rogers' strategy, key growth opportunities, capital allocation priorities and multi-year financial objectives. ...

Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.

CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE:ROG) today announced financial results for the second quarter of 2026. "We delivered another quarter of solid revenue growth, with sales increasing nearly 7% year over year, driven by improving customer demand and progress in our commercial initiatives,” stated Ali El-Haj, Rogers' President and CEO. "Compared to the prior year adjusted ...

CHANDLER, Ariz.--(BUSINESS WIRE)--Rogers Corporation (NYSE: ROG) today released its 2026 Sustainability Report, outlining Rogers' approach to managing environmental impacts, supporting employees, maintaining strong governance practices, and developing advanced materials that help customers improve efficiency and enable next-generation technologies. “We are pleased to share our 2026 Sustainabili...

Zealand Pharma said on Friday its experimental obesity drug, co-developed with Swiss partner Roche , showed encouraging tolerability in a mid-stage trial, bolstering ​its push to take on market leaders with a potentially ‌gentler alternative to existing blockbuster treatments.